Clinical Trial Update: Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating adjuvant cisplatin plus gemcitabine for operable cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Zurich | Conditions: Cholangiocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED